Guangdong Taienkang Pharmaceutical Co. Ltd (301263) - Total Liabilities

Latest as of March 2026: CN¥699.72 Million CNY ≈ $102.39 Million USD

Based on the latest financial reports, Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has total liabilities worth CN¥699.72 Million CNY (≈ $102.39 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 301263 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Guangdong Taienkang Pharmaceutical Co. Ltd - Total Liabilities Trend (2019–2025)

This chart illustrates how Guangdong Taienkang Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Guangdong Taienkang Pharmaceutical Co. L's balance sheet.

Guangdong Taienkang Pharmaceutical Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Guangdong Taienkang Pharmaceutical Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
São Martinho S.A SA:SMTO3	Brazil	R$16.05 Billion
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	China	CN¥1.03 Billion
NAVIGATOR HLDGS LTD F:1NV	Germany	€1.02 Billion
Scandi Standard publ AB ST:SCST	Sweden	Skr4.96 Billion
Porch Group Inc NASDAQ:PRCH	USA	$780.27 Million
Zhongnongfa Seed Industry Group Co Ltd SHG:600313	China	CN¥2.08 Billion
Johnson Health Tech Co Ltd TW:1736	Taiwan	NT$32.32 Billion
Bank Pan Indonesia Tbk JK:PNBN	Indonesia	Rp172.19 Trillion

Liability Composition Analysis (2019–2025)

This chart breaks down Guangdong Taienkang Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Guangdong Taienkang Pharmaceutical Co. L balance sheet independence to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.21	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.41	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.28	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Guangdong Taienkang Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2025)

The table below shows the annual total liabilities of Guangdong Taienkang Pharmaceutical Co. Ltd from 2019 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥676.07 Million ≈ $98.93 Million	+36.67%
2024-12-31	CN¥494.67 Million ≈ $72.39 Million	+23.75%
2023-12-31	CN¥399.72 Million ≈ $58.49 Million	+115.33%
2022-12-31	CN¥185.63 Million ≈ $27.16 Million	-19.89%
2021-12-31	CN¥231.71 Million ≈ $33.91 Million	-5.47%
2020-12-31	CN¥245.12 Million ≈ $35.87 Million	+35.31%
2019-12-31	CN¥181.16 Million ≈ $26.51 Million	--

About Guangdong Taienkang Pharmaceutical Co. Ltd

SHE:301263 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.20 Billion

CN¥8.20 Billion CNY

Market Cap Rank

#8180 Global

#1897 in China

Share Price

CN¥19.28

Change (1 day)

-0.67%

52-Week Range

CN¥18.05 - CN¥34.54

All Time High

CN¥41.40